Our RNAseq analysis indicates that inhibition of stemness and epithelial trans-differentiation is associated with a global transcriptional reprogramming of anillin-depleted breast cancer cells (Additional file 14: Figure S11; Additional files 12 and 13: Tables S2 and S3). This evidence concerns the gene ANLN and breast cancer.